QA: MYRIAD GENETICS INC in us_medicinal_products/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000899923_2023_MYRIAD_GENETICS_INC.pdf

Logs

info Minor missing amount for aggregate added to remainder industry.us_generic {'aggregate': 'Expenses', 'missing_ratio': 0.3433038749150238, 'aggregate_val': 790400000, 'exp_sum': 588400000, 'exp_to_value': {'GeneralAndAdministrativeExpense': 514700000, 'ResearchAndDevelopmentExpense': 85400000, 'remainder_Expenses': -11700000}}
info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0000899923, MYRIAD GENETICS INC

  xvar xval
0 LiabilitiesNoncurrent 145,400,000
1 LiabilitiesCurrent 140,700,000
2 remainder_Liabilities 26,800,000
3 AssetsCurrent 274,600,000
4 AssetsNoncurrent 174,200,000
5 PropertyPlantAndEquipmentNet 83,400,000
6 Goodwill 666,500,000
7 remainder_Assets 0
8 GeneralAndAdministrativeExpense 514,700,000
9 ResearchAndDevelopmentExpense 85,400,000
10 remainder_Expenses 190,300,000
11 remainder_Revenues 678,400,000
12 remainder_NetIncome 0
13 remainder_ComprehensiveNetIncome -3,800,000
  yvar yval
0 Liabilities 312,900,000
1 Assets 1,198,700,000
2 Expenses 790,400,000
3 Revenues 678,400,000
4 StockholdersEquity 885,800,000
5 NetIncome -112,000,000
6 ComprehensiveNetIncome -113,900,000
7 BaseVar 1,492,100,000
8 EconomicCapitalRatio 0.846

Edgar->Model Mapping

Feature Distribution

Change over Time